Showing results (161-170 of 296) with videos related to
Sort By:
Pageof 30
Bone Marrow Transplantation|June 30, 1998
Long-term follow-up after high-dose therapy for high-risk multiple myelomaB Barlogie, S Jagannath, S Naucke, et al.Cancer Research|February 15, 1989
Flow cytometric analysis of glucocorticoid receptor using monoclonal antibody and fluoresceinated ligand probesD Marchetti, N T Van, B Gametchu, et al.Carcinogenesis|April 1, 1997
Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt miceE J Beecham, J D Owens, J D Shaughnessy, et al.Oncogene|May 18, 2000
Evi27 encodes a novel membrane protein with homology to the IL17 receptorE Tian, J R Sawyer, D A Largaespada, et al.Blood Cells|January 1, 1980
Characterization of hematologic malignancies by flow cytometryB Barlogie, J Latreille, E J Freireich, et al.Cancer Research|December 1, 1977
Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphomaB Barlogie, W Hittelman, G Spitzer, et al.British Journal of Haematology|November 1, 1996
Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myelomaR Govindarajan, S Jagannath, J T Flick, et al.Cancer|May 15, 1991
A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group studyC S Higano, J Crowley, R B Livingston, et al.European Journal of Cancer & Clinical Oncology|April 1, 1984
In vitro suppression of DNA synthesis by a remission induction agent and its correlation with response in adult acute leukemiaA M Maddox, D A Johnston, B Barlogie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group studyS E Salmon, J J Crowley, T M Grogan, et al.Pageof 30